CO6821953A2 - Antagonistas de trpv4 - Google Patents
Antagonistas de trpv4Info
- Publication number
- CO6821953A2 CO6821953A2 CO13290152A CO13290152A CO6821953A2 CO 6821953 A2 CO6821953 A2 CO 6821953A2 CO 13290152 A CO13290152 A CO 13290152A CO 13290152 A CO13290152 A CO 13290152A CO 6821953 A2 CO6821953 A2 CO 6821953A2
- Authority
- CO
- Colombia
- Prior art keywords
- trpv4 antagonists
- trpv4
- antagonists
- Prior art date
Links
- 101150098315 TRPV4 gene Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161498110P | 2011-06-17 | 2011-06-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6821953A2 true CO6821953A2 (es) | 2013-12-31 |
Family
ID=47558389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO13290152A CO6821953A2 (es) | 2011-06-17 | 2013-12-11 | Antagonistas de trpv4 |
Country Status (38)
Country | Link |
---|---|
US (1) | US9187464B2 (es) |
EP (2) | EP2721016B1 (es) |
JP (1) | JP5969017B2 (es) |
KR (1) | KR101870003B1 (es) |
CN (1) | CN103732583B (es) |
AR (1) | AR086958A1 (es) |
AU (1) | AU2012284540B2 (es) |
BR (1) | BR112013032391B1 (es) |
CA (1) | CA2839743C (es) |
CL (1) | CL2013003602A1 (es) |
CO (1) | CO6821953A2 (es) |
CR (1) | CR20130671A (es) |
CY (1) | CY1117792T1 (es) |
DK (1) | DK2721016T3 (es) |
DO (1) | DOP2013000307A (es) |
EA (1) | EA023616B1 (es) |
ES (2) | ES2688733T3 (es) |
HK (1) | HK1195068A1 (es) |
HR (1) | HRP20160539T1 (es) |
HU (1) | HUE029594T2 (es) |
IL (1) | IL229872A (es) |
JO (1) | JO3154B1 (es) |
MA (1) | MA35184B1 (es) |
ME (1) | ME02416B (es) |
MX (1) | MX337440B (es) |
MY (1) | MY173521A (es) |
PE (1) | PE20141943A1 (es) |
PL (1) | PL2721016T3 (es) |
PT (1) | PT2721016E (es) |
RS (1) | RS54858B1 (es) |
SG (1) | SG195106A1 (es) |
SI (1) | SI2721016T1 (es) |
SM (1) | SMT201600150B (es) |
TW (1) | TWI538912B (es) |
UA (1) | UA113963C2 (es) |
UY (1) | UY34138A (es) |
WO (1) | WO2013012500A1 (es) |
ZA (1) | ZA201308816B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2595606T3 (es) * | 2011-06-17 | 2017-01-02 | Glaxosmithkline Intellectual Property (No. 2) Limited | Antagonistas TRPV4 |
WO2012174342A1 (en) | 2011-06-17 | 2012-12-20 | Glaxosmithkline Llc | Trpv4 antagonists |
JPWO2013146754A1 (ja) | 2012-03-27 | 2015-12-14 | 塩野義製薬株式会社 | Trpv4阻害活性を有する芳香族複素5員環誘導体 |
JPWO2015046193A1 (ja) | 2013-09-25 | 2017-03-09 | 塩野義製薬株式会社 | Trpv4阻害活性を有する芳香族複素環式アミン誘導体 |
US10968209B2 (en) | 2016-05-19 | 2021-04-06 | Glaxosmithkline Intellectual Property (No.2) Limited | TRPV4 antagonist |
KR20190005877A (ko) * | 2016-05-19 | 2019-01-16 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | Trpv4 길항제 |
AU2017338269B2 (en) | 2016-10-03 | 2021-03-25 | Janssen Pharmaceutica Nv | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors |
WO2018185701A1 (en) | 2017-04-06 | 2018-10-11 | Glaxosmithkline Intellectual Property (No.2) Limited | Trpv4 antagonists as antitussive agents |
ES2933184T3 (es) * | 2017-11-01 | 2023-02-02 | Bristol Myers Squibb Co | Compuestos espirocíclicos como moduladores del receptor farnesoide X |
WO2021170811A1 (en) | 2020-02-27 | 2021-09-02 | Glaxosmithkline Intellectual Property (No.2) Limited | Method of treating eye disease using trpv4 antagonists |
WO2021221169A1 (en) | 2020-04-30 | 2021-11-04 | Raqualia Pharma Inc. | Pyrimidin-4(3h)-one derivatives as trpv4 antagonists |
CN111704613B (zh) * | 2020-06-23 | 2021-07-06 | 中国人民解放军军事科学院军事医学研究院 | 咪唑类衍生物及其作为trpv4抑制剂的用途 |
MX2023000610A (es) * | 2020-07-16 | 2023-02-13 | Raqualia Pharma Inc | Inhibidor de trpv4 como agente terapeutico para enfermedades oculares. |
TW202409024A (zh) | 2022-07-08 | 2024-03-01 | 美商愛克堤歐生物科學公司 | 治療性化合物及方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1086950B1 (en) * | 1998-05-26 | 2010-09-29 | Chugai Seiyaku Kabushiki Kaisha | Heterocyclic indole derivatives and mono- or diazaindole derivatives |
CA2531619A1 (en) * | 2003-07-16 | 2005-01-27 | Neurogen Corporation | Biaryl piperazinyl-pyridine analogues |
WO2007059608A1 (en) * | 2005-11-23 | 2007-05-31 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
WO2007067756A2 (en) | 2005-12-08 | 2007-06-14 | Amphora Discovery Corporation | Certain chemical entities, compositions, and methods for modulating trpv1 |
CN102499921A (zh) * | 2005-12-22 | 2012-06-20 | 海德拉生物科学公司 | 治疗疼痛的方法和组合物 |
TW200819457A (en) * | 2006-08-30 | 2008-05-01 | Actelion Pharmaceuticals Ltd | Spiro antibiotic derivatives |
US20090042897A1 (en) * | 2007-02-01 | 2009-02-12 | Glaxo Group Limited | Chemical Compounds |
GB0707934D0 (en) * | 2007-04-24 | 2007-05-30 | Glaxo Group Ltd | Chemical compounds |
CA2708320A1 (en) * | 2007-08-09 | 2009-02-19 | Abbott Laboratories | Amide derivatives as trpv1 antagonists |
TW200944520A (en) * | 2008-01-29 | 2009-11-01 | Glaxo Group Ltd | Spiro compounds as NPY Y5 receptor antagonists |
US8450484B2 (en) * | 2008-07-25 | 2013-05-28 | GlaxoSmithKline, LLC | TRPV4 antagonists |
JP2012006837A (ja) * | 2008-09-30 | 2012-01-12 | Mochida Pharmaceut Co Ltd | 2−インドールアクリルアミド類縁体 |
EP2605658B1 (en) | 2010-08-18 | 2016-03-23 | Merck Sharp & Dohme Corp. | Spiroxazolidinone compounds |
WO2012174342A1 (en) * | 2011-06-17 | 2012-12-20 | Glaxosmithkline Llc | Trpv4 antagonists |
ES2595606T3 (es) * | 2011-06-17 | 2017-01-02 | Glaxosmithkline Intellectual Property (No. 2) Limited | Antagonistas TRPV4 |
-
2012
- 2012-06-14 JO JOP/2012/0159A patent/JO3154B1/ar active
- 2012-06-15 KR KR1020147000958A patent/KR101870003B1/ko not_active Application Discontinuation
- 2012-06-15 HU HUE12814591A patent/HUE029594T2/en unknown
- 2012-06-15 PE PE2013002807A patent/PE20141943A1/es active IP Right Grant
- 2012-06-15 RS RS20160417A patent/RS54858B1/sr unknown
- 2012-06-15 AR ARP120102143A patent/AR086958A1/es active IP Right Grant
- 2012-06-15 UY UY0001034138A patent/UY34138A/es not_active Application Discontinuation
- 2012-06-15 EP EP12814591.9A patent/EP2721016B1/en active Active
- 2012-06-15 ME MEP-2016-120A patent/ME02416B/me unknown
- 2012-06-15 SG SG2013086483A patent/SG195106A1/en unknown
- 2012-06-15 AU AU2012284540A patent/AU2012284540B2/en active Active
- 2012-06-15 EP EP16162808.6A patent/EP3121177B1/en active Active
- 2012-06-15 PL PL12814591T patent/PL2721016T3/pl unknown
- 2012-06-15 EA EA201490037A patent/EA023616B1/ru not_active IP Right Cessation
- 2012-06-15 ES ES16162808T patent/ES2688733T3/es active Active
- 2012-06-15 US US14/125,378 patent/US9187464B2/en active Active
- 2012-06-15 WO PCT/US2012/042622 patent/WO2013012500A1/en active Application Filing
- 2012-06-15 BR BR112013032391-4A patent/BR112013032391B1/pt active IP Right Grant
- 2012-06-15 MY MYPI2013702447A patent/MY173521A/en unknown
- 2012-06-15 TW TW101121449A patent/TWI538912B/zh active
- 2012-06-15 CA CA2839743A patent/CA2839743C/en active Active
- 2012-06-15 SI SI201230564A patent/SI2721016T1/sl unknown
- 2012-06-15 UA UAA201400152A patent/UA113963C2/uk unknown
- 2012-06-15 CN CN201280039690.0A patent/CN103732583B/zh active Active
- 2012-06-15 JP JP2014516020A patent/JP5969017B2/ja active Active
- 2012-06-15 ES ES12814591T patent/ES2569193T3/es active Active
- 2012-06-15 MX MX2013014898A patent/MX337440B/es active IP Right Grant
- 2012-06-15 DK DK12814591.9T patent/DK2721016T3/en active
- 2012-06-15 PT PT128145919T patent/PT2721016E/pt unknown
-
2013
- 2013-11-22 ZA ZA2013/08816A patent/ZA201308816B/en unknown
- 2013-12-09 IL IL229872A patent/IL229872A/en active IP Right Grant
- 2013-12-11 CO CO13290152A patent/CO6821953A2/es active IP Right Grant
- 2013-12-13 MA MA36564A patent/MA35184B1/fr unknown
- 2013-12-16 CL CL2013003602A patent/CL2013003602A1/es unknown
- 2013-12-17 DO DO2013000307A patent/DOP2013000307A/es unknown
- 2013-12-17 CR CR20130671A patent/CR20130671A/es unknown
-
2014
- 2014-08-20 HK HK14108527.9A patent/HK1195068A1/zh unknown
-
2016
- 2016-05-19 HR HRP20160539TT patent/HRP20160539T1/hr unknown
- 2016-05-31 SM SM201600150T patent/SMT201600150B/it unknown
- 2016-06-21 CY CY20161100556T patent/CY1117792T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201600476B (it) | Tenofovir alafenammide emifumarato | |
BR112013020402A2 (pt) | antagonistas pcsk9 | |
BR112013028983A2 (pt) | antagonistas mdm2 espiro-oxindol | |
CO6821953A2 (es) | Antagonistas de trpv4 | |
DK2794626T6 (da) | E-selectin-antagonistforbindelser | |
BR112014002399A2 (pt) | conjunto | |
DK2769050T3 (da) | Propsensor | |
BR112014000879A2 (pt) | deflegmador | |
EP2720546A4 (en) | TRPV4 Antagonist | |
DK3272861T3 (da) | Alpha-galactosidase-sammensætninger | |
CO6960543A2 (es) | 2-tiopirimidinonas | |
DE102011100082A8 (de) | Traygreifvorrichtung | |
EP2720697A4 (en) | TRPV4 Antagonist | |
DK3141251T3 (da) | Koloskopi - forberedelse | |
DE112011104936A5 (de) | Stanzstauchniet | |
DE112012000958A5 (de) | Handsäge | |
DK2476953T3 (da) | Fluidbedkedel | |
DE112012002458A5 (de) | Hydrotransformator | |
DE112012000819A5 (de) | Gurtbandfänger | |
DE112012005313A5 (de) | Leuchtbild | |
DK2526750T3 (da) | Høbjærgningsmaskine | |
DE112012001294T8 (de) | Umspritzungsverfahren | |
FR2976926B1 (fr) | Caisse-outre | |
DE102011117169A8 (de) | Absetzplattenanordnung | |
DE112011105396A5 (de) | Nachverfestigungsverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted |